Erratum: P-cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation (Inflammation DOI: 10.1007/s10753-012-9574-y);P-cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation

Inflammation

Volumn 36, Issue 3, 2013, Pages 529-537

  Zhong, Weiting ^a   Chi, Gefu ^b   Jiang, Lanxiang ^c   Soromou, Lanan Wassy ^a   Chen, Na ^a   Huo, Meixia ^a   Guo, Weixiao ^a   Deng, Xuming ^a   Feng, Haihua ^a  

^a JILIN UNIVERSITY   (China)

^b INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

inflammation; LPS; MAPKs; NF B; p cymene

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PARA CYMENE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CELL STRAIN RAW 264.7; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MUS;

EID: 84877774613     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9618-y     Document Type: Erratum

References (38)

1. Bone, R.C., C.J. Grodzin, and R.A. Balk. 1997. Sepsis, a new hypothesis for pathogenesis of the disease process. Chest 112: 235-243.
2. Glauser, M.P., D. Heumann, J.D. Baumgartner, and J. Cohen. 1994. Pathogenesis and potential strategies for prevention and treatment of septic shock: An update. Clinical Infectious Diseases 2: 205-216.
3. Adams, D.O. 1994. Molecular biology of macrophage activation: A pathway whereby psychosocial factors can potentially affect health. Psychosomatic Medicine 56: 316-327.
4. Morrison, D.C., and J.L. Ryan. 1987. Endotoxin and disease mechanisms. Annual Review of Medicine 38: 417-432.
5. Porter, K.J., B. Gonipeta, S. Parvataneni, and D. Appledorn. 2010. M. Patial S. Sharma D, et al. Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. Journal of Cellular Physiology 225: 406-416.
6. Baeuerle, P.A., and D. Baltimore. 1996. NF-kappa B: Ten years after. Cell 87: 13-20.
7. Guha, M., M.A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S.F. Yan, et al. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98: 1429-1439.
8. Hall, A.J., H.L. Vos, and R.M. Bertina. 1999. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappa B nuclear translocation. Journal of Biological Chemistry 274: 376-383.
9. Hambleton, J., S.L. Weinstein, L. Lem, and A.L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proceedings of the National Academy of Sciences of the United States of America 93: 2774-2778.
10. 13C-NMR spectroscopy: Quantitative determination of ascaridole, a heat-sensitive compound. Phytochemical Analysis 15: 275-279.
11. Khokra, S.L., O. Prakash, S. Jain, K.R. Aneja, and Y. Dhingra. 2008. Essential oil composition and antibacterial studies of Vitex negundo Linn. extracts. Indian Journal of Pharmaceutical Sciences 70: 522-526.
12. Alma, M.H., A. Mavi, A. Yildirim, M. Digrak, and T. Hirata. 2003. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biological and Pharmaceutical Bulletin 26: 1725-1729.
13. Raza, M., A.A. Alghasham, M.S. Alorainy, and T.M. El-Hadiyah. 2008. Potentiation of valproate-induced anticonvulsant response by Nigella sativa seed constituents: The role of GABA receptors. International Journal of Health Sciences 2: 15-25.
14. Zhang, X., Y. Song, X. Ci, N. An, J. Fan, J. Cui, et al. 2008. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. International Immunopharmacology 8: 982-988.
15. Remick, D.G., R.G. Kunkel, J.K. Larrick, and S.L. Kunkel. 1987. Acute in vivo effects of human recombinant tumor necrosis factor. Laboratory Investigation 56: 583-590.
16. Beutler, B., and A. Cerami. 1988. Tumor necrosis, cachexia, shock, and inflammation: A common mediator. Annual Review of Biochemistry 57: 505-518.
17. Dinarello, C.A. 1984. Interleukin-1. Reviews of Infectious Diseases 6: 51-95.
18. Hack, C.E., E.R. De Groot, R.J. Felt-Bersma, J.H. Nuijens, R.J. Strack Van Schijndel, A.J. Eerenberg-Belmer, et al. 1989. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704-1710.
19. Okusawa, S., J.A. Gelfand, T. Ikejima, R.J. Connolly, and C.A. Dinarello. 1988. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. The Journal of Clinical Investigation 81: 1162-1172.
20. Waage, A., A. Halstensen, and T. Espevik. 1987. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355-337.
21. Nijsten, M.W., E.R. de Groot, H.J. ten Duis, H.J. Klasen, C.E. Hack, and L.A. Aarden. 1987. Serum levels of intenleukin-6 and acute phase responses. Lancet 2: 921.
22. Helle, M., J.P. Brakenhoff, E.R. De Groot, and L.A. Aarden. 1988. Interleukin 6 is involved in interleukin-1-induced activities. European Journal of Immunology 18: 957-959.
23. Hack, C.E., E.R. De Groot, R.J. Felt-Bersma, and J.H. Nuijens. 1989. Strack Van Schijndel RJ, Eerenberg-Belmer AJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704-1710.
24. Walley, K.R., N.W. Lukacs, T.J. Standiford, R.M. Strieter, and S.L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infection and Immunity 64: 4733-4738.
25. de Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. The Journal of Experimental Medicine 174: 1209-1220.
26. Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147: 3815-3822.
27. Gerard, C.C., A. Bruyns, D. Marchant, P. Abramowicz, A. Vandenabeele, W. Delvaux, et al. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. The Journal of Experimental Medicine 177: 547-550.
28. Marchant, A.C., P. Bruyns, M. Vandenabeele, C. Ducarme, A. Gerard, D. Delvaux, et al. 1994. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. European Journal of Immunology 24: 1167-1171.
29. Takeuchi, O., S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, et al. 2002. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. The Journal of Immunology 169: 10-14.
30. Su, H., N. Bidère, L. Zheng, A. Cubre, K. Sakai, J. Dale, et al. 2005. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307: 1465-1468.
31. van der Bruggen, T., S. Nijenhuis, E. van Raaij, J. Verhoef, and B.S. van Asbeck. 1999. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infection and Immunity 67: 3824-3829.
32. Andersson, K., and R. Sundler. 2000. Signaling to translational activation of tumour necrosis factor-alpha expression in human THP-1 cells. Cytokine 12: 1784-1787.
33. Xagorari, A., C. Roussos, and A. Papapetropoulos. 2002. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. British Journal of Pharmacology 136: 1058-1064.
34. Swantek, J.L., M.H. Cobb, and T.D. Geppert. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Molecular and Cellular Biology 17: 6274-6282.
35. Carter, A.B., M.M. Monick, and G.W. Hunninghake. 1999. Both Erk and p38 kinases are necessary for cytokine gene transcription. American Journal of Respiratory Cell and Molecular Biology 20: 751-758.
36. Ajizian, S.J., B.K. English, and E.A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ. Journal of Infectious Diseases 179: 939-944.
37. Mlienhard, S., A. Marcos, and A. Patrick. 1995. Transactivation domain 2 (TA2) of NF-κB p65. The Journal of Biological Chemistry 270: 15576-15584.
38. 56Fe ions. Radiation and Environmental Biophysics 41: 139-44.